Circulating β-cell-specific CD8+ T cells restricted by high risk HLA class I molecules show antigen experience in children with and at risk of type 1 diabetes

Lorraine Yeo, Irma Pujol-Autonell, Roman Baptista, Martin Eichmann, Deborah Kronenberg-Versteeg, Susanne Heck, Garry Dolton, Andrew K Sewell, Taina Härkönen, Mari-Liis Mikk, Jorma Toppari, Riitta Veijola, Mikael Knip, Jorma Ilonen, Mark Peakman

Department of Immunobiology, Faculty of Life Sciences & Medicine, King's College London, London, UK [email protected].
National Institute of Health Research Biomedical Research Centre at Guy's and St Thomas' Hospital and King's College London, London SE19RT, UK.
Cardiff University
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.
Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku, Turku, Finland.
Department of Paediatrics, PEDEGO Research Unit, Medical Research Centre, Oulu University Hospital and University of Oulu, Oulu, Finland.
Folkhälsan Research Centre, Helsinki, Finland.
Clinical Microbiology, Turku University Hospital, Turku, Finland.
King's Health Partners Institute of Diabetes, Endocrinology and Obesity, UK.

Research output: Contribution to journal › Article › peer-review

28 Citations (Scopus)

Immunology and Microbiology